Showing results (231-240 of 292) with videos related to

Sort By:
Pageof 30
Antimicrobial Agents and Chemotherapy|March 16, 2011
Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysisKiwon Kim, Young-Hwan Hwang, Han Ro, et al.
Therapeutic Drug Monitoring|August 30, 2012
Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 casesMin Kyu Park, Kyoung Soo Lim, Tae-Eun Kim, et al.
Breast Cancer Research and Treatment|July 6, 2006
Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancerJi-Yeob Choi, Kyoung-Mu Lee, Dong-Young Noh, et al.
Clinical Therapeutics|November 20, 2009
Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteersTae-Eun Kim, Bo-Hyung Kim, JaeWoo Kim, et al.
Clinical Pharmacology and Therapeutics|October 4, 2021
Pharmacokinetic and Pharmacodynamic Characteristics of Tripegfilgrastim, a Pegylated G-CSF, in Pediatric Patients with Solid TumorsSoyoung Lee, Kyung Taek Hong, Seol Ju Moon, et al.
Psychopharmacology|December 29, 2012
The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazoleEuitae Kim, Oliver D Howes, Federico E Turkheimer, et al.
Clinical Therapeutics|August 4, 2010
Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteersNamyi Gu, Bo-Hyung Kim, HyouYoung Rhim, et al.
Basic & Clinical Pharmacology & Toxicology|July 9, 2013
Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male ParticipantsYu-Jung Cha, Howard Lee, Namyi Gu, et al.
Therapeutic Drug Monitoring|March 1, 2014
Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoringHye Kyung Han, Hyungmi An, Kwang-Hee Shin, et al.
Scientific Reports|June 29, 2017
Korean Variant Archive (KOVA): a reference database of genetic variations in the Korean populationSangmoon Lee, Jihae Seo, Jinman Park, et al.
Pageof 30